Self-presentation of the website
The European Medicines Agency publishes these data so that its stakeholders, including the general public, can access information that European regulatory authorities use to review the safety of a medicine or active substance. Transparency is a key guiding principle of the Agency.
Comment of the editorial staff of this website: Transparency???
The information on this website relates to suspected side effects, i.e. medical events that have been observed following the use of a medicine, but which are not necessarily related to or caused by the medicine.
Comment of the editorial staff of this website: Of course not! (Irony off!)
Information on suspected side effects should not be interpreted as meaning that the medicine or the active substance causes the observed effect or is unsafe to use. Only a detailed evaluation and scientific assessment of all available data allows for robust conclusions to be drawn on the benefits and risks of a medicine.
Comment of the editorial staff of this website: Naturally they are not unsafe to use, not at all, of course not! (Irony off!)
Comment of the editorial staff
According to experts, about 90 % of adverse side effects are not reported. But even the 10 % reported are overwhelming.
How to use the database
If you want to analyze the database yourself, here is a checklist
